IL-17 is one of the central molecules of the Th17/IL-23 axis that interferes with hepatic steatosis in nonalcoholic fatty liver disease (NAFLD), and insulin signalling and IL-17R expression correlate with insulin resistance [16,17]. This evidence concerns the gene IL17RA and metabolic dysfunction-associated steatotic liver disease.